Insight, The Journal of ASORN ASORN Insight 2018 Q3 - Page 38

36 Viewpoint Continued from page 4 setting (IOM, 2010). In this complex health care environment nurses may encounter many uncertainties in their practice, yet the opportunities for leadership, innova- tion, influence, role enhancement, and demonstrating nursing value have never been more critical. Strong and immediate ambulatory care nurse actions are identified to improve health and display their value. Among these are (AAACN, 2017, p.45): • Communicate the story of ambulatory care nurses and their ability to positively impact outcomes. • Ensure robust clinical documentation tools are in place to support practice. • Expand nursing knowledge by applying or conducting scientific studies. • Establish health system and academic institution alliances to prepare ambulatory care nurses. • Develop an agenda that informs others – the nursing community, health care professionals, and other stakeholders – of ambulatory care nurses’ value and cost effectiveness. Professional nurses are the most versatile member of the health care team. They carry the knowledge and expertise to posi- tively impact health by providing greater access to health care services, decreasing costs, and improving quality. Ophthalmic nurses should seize this opportunity to describe and demonstrate their value. Kathleen Mertens is President-Elect for the American Academy of Ambulatory Care Nursing (AAACN). She is Assistant Administrator for Ambulatory Nursing Practice, Quality & Safety, Harborview Medical Center, Seattle, WA. Dr. Mertens can be reached at kmertens@uw.edu • Lead organizational efforts to define and implement nursing roles that promote References autonomy, collaboration, care coordina- American Academy of Ambulatory Care Nursing (AAACN). (2017). American Academy of Ambulatory Care Nursing position paper: The role of the registered nurse in ambulatory care. Nursing Economic$, 35(1), 39-47. tion, transition management, and improve practice. • Design cultures and structures that pro- mote and reward innovation. Bureau of Labor Statistics, U.S. Department of Labor. (2016). Occupational Outlook Handbook, Registered Nurses. Retrieved from https://www.bls.gov/ooh/healthcare/ registered-nurses.htm to voice, what nurses know and must communicate to the public. Ithaca, NY: Cornell University Press. Centers for Disease Control. (2010). National Ambulatory Medical Care Survey factsheet – Ophthalmology. Retrieved from https:// www.cdc.gov/nchs/data/ahcd/namcs_2010_ factsheet_ophthalmology.pdf Clouser, S. (2015, summer). Ophthalmic nursing: More than meets the eye. Insight: The Journal of the American Society of Ophthalmic Registered Nurses, 40(3), 3. Hall, M.J., Schwartzman, A., Zhang, J. & Liu, X. (2017, February 28). Ambulatory surgery data from hospitals and ambulatory surgery centers: United States, 2010. National health statistics reports; no 102. Hyattsville, MD: National Center for Health Statistics. Institute of Medicine. (2011). The future of nursing: Leading change, advancing health. Washington, DC: National Academies Press. Retrieved from http://www. nationalacademies.org/hmd/Reports/2010/ The-Future-of-Nursing-Leading-Change- Advancing-Health.aspx Marsden, J. (2014, summer). The nature, scope and value of ophthalmic nursing. Insight: The Journal of the American Society of Ophthalmic Registered Nurses, 39(3), 14-17. Mastal, M., Matlock, A.M., & Start, R. (2016). Capturing the role of nursing in ambulatory care: The case for meaningful nurse-sensitive measurement. Nurse Economic$, 34(2), 92-97, 76. National Academies of Sciences, Engineering, and Medicine. (2016). Making eye health a population health imperative: Vision for tomorrow. Washington, DC: The National Academies Press. Start, R., Matlock, A.M., & Mastal, P. (2016). Ambulatory care nurse-sensitive indicator industry report: Meaningful measurement of nursing in the ambulatory patient care environment. Pitman, NJ: American Academy of Ambulatory Care Nursing. Buresh, B. & Gordon, S. (2013). From silence Systemic Surveillance Options Following Uveal Melanoma Prognostication Continued from page 26 References Aalto, Y., Eriksson, L., Seregard, S., Larsson, O., & Knuutila, S. (2001). Concomitant loss of chromosome 3 and whole arm losses and gains of chromosome 1, 6, or 8 in metastasizing primary uveal melanoma. Investigative Ophthalmology and Visual Science, 42(2), 313–317. Choudhary, M. M., Gupta, A., Bena, J., Emch, T., & Singh, A. D. (2016). Hepatic ultrasonography for surveillance in patients with uveal melanoma. JAMA Ophthalmology, 134(2), 174–180. doi:10.1001/ jamaophthalmol.2015.4810 Davanzo, J., Bellerive, C., Petrich, D., & Singh, A. D. (2017). Acceptance of prognostic fine needle aspiration biopsy for uveal melanoma. Insight, 42(3), 12–14. ASORN INSIGHT Summer 2018 Diener-West, M., Reynolds, S. M., Agugliaro, D. J., Caldwell, C., Cumming, K., Earle, J. D. … Thoma, J.; Collaborative Ocular Melanoma Study Group. (2004). Screening for metastasis from choroidal melanoma: The Collaborative Ocular Melanoma Study Group report 23. Journal of Clinical Oncology, 22(12), 2438–2444. Diener-West, M., Reynolds, S. M., Agugliaro, D. J., Caldwell, C., Cumming, K., Earle, J. D. … Thoma, J.; Collaborative Ocular Melanoma Study Group. (2005). Development of metastatic disease after enrollment in the COMS trials for tr VFV@b6&FV6&&FfP7V"V7GVGw&W&W'B#b&6fW2bFw#2"c3( 3cC2षVR:FFRBbfV:BB#2fW'rFW&&v62bFVG2vFƖvBWfVVfW7FvFfPFwBf7V66V6RCBCcS( 3CcSG&WBWRVV&vBFV7&VR2FVGG&R6WGW&W"ࢃ#vV֖2&fƖrBFVFf6Fbv&6WfVV''&4tǗ62b&'GV'2BƗfW WF7F6W2fW7FvFfRFwBf7V66V6RSb#Ss.( 3#SFcrg2##`